- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Central Library of Charles University
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAMN107EIC01Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: CAMN107AIC05Publication without faculty affiliation
- Serum and lymph pharmacokinetics of nilotinib delivered by yeast glucan particles per os2023 | First Faculty of Medicine, Faculty of Science
- Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia2013 | First Faculty of Medicine
- Treatment of gastrointestinal stromal tumours2010 | Second Faculty of Medicine
- Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy2018 | First Faculty of Medicine
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patientPublication without faculty affiliation
- Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors2016 | First Faculty of Medicine
- Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease2012 | First Faculty of Medicine
- BCR-ABL mutation analysis allows to provide "tailors therapy" for CML patients resistant to imatinib2010 | Faculty of Medicine in Hradec Králové
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient2010 | Faculty of Medicine in Pilsen
- New developments in the management of gastrointestinal stromal tumour.2011 | First Faculty of Medicine
- Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib2017 | Publication without faculty affiliation
- Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients - results from real-life prospective study2020 | Faculty of Medicine in Hradec Králové
- Treatment of chronic myeloid leukemia in adults in 20102010 | Faculty of Medicine in Hradec Králové
- Gastrointestinal stromal tumor2008 | Publication without faculty affiliation
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- ABL1, SRC and other non-receptor tyrosine-kinases as new targets for specific anticancer therapy2010 | First Faculty of Medicine
- 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation2022 | Publication without faculty affiliation
- Bosutinib v léčbě chronické myeloidní leukemie2019 | Faculty of Medicine in Hradec Králové
- Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib2021 | Faculty of Pharmacy in Hradec Králové
- Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party2021 | Publication without faculty affiliation